Triamcinolone Acetonide Injectable Suspension Shortage

• • Triamcinolone acetonide injection, Eugia US, 40 mg/mL, 10 mL vial, 1 count, NDC 55150-0385-01
  • Triamcinolone acetonide injection, Eugia US, 40 mg/mL, 5 mL vial, 1 count, NDC 55150-0384-01
  • Triamcinolone acetonide injection, Hikma, 40 mg/mL, 1 mL vial, 25 count, NDC 00143-9387-25
  • Triamcinolone acetonide injection, Long Grove Pharmaceuticals, 40 mg/mL, 10 mL vial, 1 count, NDC 81298-5783-03
  • Triamcinolone acetonide injection, Long Grove Pharmaceuticals, 40 mg/mL, 5 mL vial, 1 count, NDC 81298-5785-03
  • Triamcinolone acetonide injection, Mylan (Viatris), 40 mg/mL, 1 mL vial, 25 count, NDC 67457-0621-99
  • Triamcinolone acetonide injection, Teva, 40 mg/mL, 10 mL vial, 1 count, NDC 00703-0245-01

• • Amneal has triamcinolone acetonide injectable suspension available.
  • Eugia did not provide a reason for the shortage.
  • Hikma did not provide a reason for the shortage.
  • Long Grove has triamcinolone acetonide injectable suspension on shortage due to increased demand.
  • Teva did not provide a reason for the shortage.
  • Viatris did not provide a reason for the shortage.
  • BMS has Kenalog injectable suspension available, but a disruption expected this fall.

• • Kenalog-10 injection, Bristol-Myers Squibb, 10 mg/mL, 5 mL vial, 1 count, NDC 00003-0494-20
  • Kenalog-40 injection, Bristol-Myers Squibb, 40 mg/mL, 1 mL vial, 1 count, NDC 00003-0293-05
  • Kenalog-40 injection, Bristol-Myers Squibb, 40 mg/mL, 10 mL vial, 1 count, NDC 00003-0293-28
  • Kenalog-40 injection, Bristol-Myers Squibb, 40 mg/mL, 5 mL vial, 1 count, NDC 00003-0293-20
  • Kenalog-80 injection, Bristol-Myers Squibb, 80 mg/mL, 1 mL vial, 1 count, NDC 00003-0315-05
  • Kenalog-80 injection, Bristol-Myers Squibb, 80 mg/mL, 5 mL vial, 1 count, NDC 00003-0315-20
  • Triamcinolone acetonide injection, Amneal, 40 mg/mL, 1 mL vial, 25 count, NDC 70121-1049-05
  • Triamcinolone acetonide injection, Amneal, 40 mg/mL, 10 mL vial, 1 count, NDC 70121-1169-01
  • Triamcinolone acetonide injection, Amneal, 40 mg/mL, 5 mL vial, 1 count, NDC 70121-1168-01
  • Triamcinolone acetonide injection, Mylan (Viatris), 40 mg/mL, 10 mL vial, 25 count, NDC 67457-0623-99
  • Triamcinolone acetonide injection, Mylan (Viatris), 40 mg/mL, 5 mL vial, 25 count, NDC 67457-0622-99
  • Triamcinolone acetonide injection, Teva, 40 mg/mL, 1 mL vial, 1 count, NDC 00703-0241-01
  • Triamcinolone acetonide injection, Teva, 40 mg/mL, 5 mL vial, 1 count, NDC 00703-0243-01

Estimated Resupply Dates

• • Eugia has triamcinolone acetonide injectable suspension in 40 mg/mL 5 mL and 10 mL vials on intermittent back order and the company is releasing product as it becomes available.
  • Hikma has triamcinolone acetonide injectable suspension in 40 mg/mL 1 mL vials on back order and the company estimates a release date of late-June to early-July 2025.
  • Long Grove has triamcinolone acetonide injectable suspension in 40 mg/mL 5 mL and 10 mL vials on allocation.
  • Teva has triamcinolone acetonide injectable suspension in 40 mg/mL 10 mL vials on back order and the company cannot estimate a release date.
  • Viatris has triamcinolone acetonide injectable suspension in 40 mg/mL 1 mL vials on back order and the company estimates a release date of early-June 2025.